Acro Biomedical Co., Ltd. (ACBM)
OTCMKTS
· Delayed Price · Currency is USD
0.0260
0.00 (0.00%)
At close: Apr 20, 2026
Acro Biomedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0 | 0 | 0 | 0.01 | 0.1 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0 | 0 | 0.01 | 0.1 | Upgrade
|
| Cash Growth | 760.92% | 26.60% | -93.58% | -93.86% | 425.56% | Upgrade
|
| Receivables | - | - | - | 0.64 | 0.6 | Upgrade
|
| Inventory | - | - | - | 0.01 | 0.01 | Upgrade
|
| Prepaid Expenses | 0.01 | - | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | - | 0 | - | - | - | Upgrade
|
| Total Current Assets | 0.01 | 0.01 | 0 | 0.66 | 0.71 | Upgrade
|
| Property, Plant & Equipment | - | 0.03 | 0.05 | 0.03 | 0.05 | Upgrade
|
| Other Long-Term Assets | - | - | 0 | 0 | 0 | Upgrade
|
| Total Assets | 0.01 | 0.03 | 0.06 | 0.69 | 0.76 | Upgrade
|
| Accounts Payable | 0.06 | 0.15 | 0.15 | 0.08 | 0.03 | Upgrade
|
| Short-Term Debt | 0.33 | 0.13 | 0.09 | 0.08 | 0.02 | Upgrade
|
| Current Portion of Leases | - | 0.03 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Current Unearned Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Total Current Liabilities | 0.4 | 0.33 | 0.29 | 0.2 | 0.09 | Upgrade
|
| Long-Term Leases | - | - | 0.03 | - | 0.03 | Upgrade
|
| Total Liabilities | 0.4 | 0.33 | 0.32 | 0.2 | 0.12 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 32.31 | 32.3 | 32.3 | 32.3 | 32.29 | Upgrade
|
| Retained Earnings | -32.76 | -32.66 | -32.62 | -23.81 | -7.94 | Upgrade
|
| Comprehensive Income & Other | - | - | - | -8.06 | -23.77 | Upgrade
|
| Shareholders' Equity | -0.39 | -0.29 | -0.26 | 0.49 | 0.64 | Upgrade
|
| Total Liabilities & Equity | 0.01 | 0.03 | 0.06 | 0.69 | 0.76 | Upgrade
|
| Total Debt | 0.33 | 0.15 | 0.14 | 0.1 | 0.07 | Upgrade
|
| Net Cash (Debt) | -0.32 | -0.15 | -0.14 | -0.1 | 0.02 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.00 | -0.00 | -0.00 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 60.04 | 60.04 | 60.04 | 60.04 | 60.04 | Upgrade
|
| Total Common Shares Outstanding | 60.04 | 60.04 | 60.04 | 60.04 | 60.04 | Upgrade
|
| Working Capital | -0.39 | -0.32 | -0.29 | 0.46 | 0.61 | Upgrade
|
| Book Value Per Share | -0.01 | -0.00 | -0.00 | 0.01 | 0.01 | Upgrade
|
| Tangible Book Value | -0.39 | -0.29 | -0.26 | 0.49 | 0.64 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.00 | -0.00 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.